Hi friends!!!
In our previous blogs, we have discussed about the following topics.
EU MDR Timeline, Annex, Chapter
EU MDR Post Market Surveillance
EU MDR Technical Documentation - Part 1
EU MDR Technical Documentation - Part 2
EU MDR General Safety and Performance Requirement
EU MDR Information on the Label
EU MDR Post Market Clinical Follow Up
EU MDR Unique Device Identification - Part 1
EU MDR Unique Device Identification - Part 2
EU MDR Chapter & Articles - Part 1
EU MDR Chapter & Articles - Part 2
EU MDR 2017/745 is live now. And it is the most trending topic in Medical Device Regulatory Affairs field. Most of the medical device companies are in EU MDR Transition to make sure that they can sell their products in Europe.
Therefore, it is important for Medical Device QA/RA Professionals to know in detail about EU MDR 2017/745. In today's blog, we are going to discuss about the requirements of Custom-Made Devices as per EU MDR 2017/745.
Let's get into the topic.
Procedures for Custom-Made Devices
In EU MDR 2017/745, Annex XIII provides the requirements for Custom-Made Devices. Let's discuss about the requirements.
For Custom made devices, the statement containing the
following information shall be provided by the manufacturer or authorized
representative of the custom-made medical device:
The name and address of the manufacturer and all of their manufacturing sites. If applicable, name and address of the authorized representative shall also be provided.
The name of the person who made the prescription for the custom-made device and who is authorized by the national law based on their professional qualifications to make such prescription. The name of the concerned health institution shall also be provided.
As indicated by the prescription, information about any
specific characteristics of the custom-made device shall be provided.
Information that the custom-made device will be
exclusively used by a particular patient or a user shall be provided as a
statement. The statement shall also identify the name, an acronym or a
numerical code.
A statement that the custom-made device in question
conforms to Annex I, General Safety and Performance Requirements of EU MDR
2017/745 shall be provided. If applicable, information about any general safety
and performance requirements which have not been fully met shall be provided.
If applicable, information that the custom-made device
contains or incorporates a medicinal substance, including a human blood or
plasma derivative, or tissues or cells of human origin, or of animal origin
shall be provided.
Any data allowing the identification of the custom-made device in question.
The manufacturer of the custom-made device shall keep
available the documentation containing information about their manufacturing
sites for the competent authorities. The documentation shall also allow an
understanding to be formed regarding the design, manufacture and performance of
the custom-made device, including its expected performance, so as to allow the
assessment of conformity by the competent authorities with respect to the
requirements of EU MDR 2017/745.
The manufacturer of the custom-made device shall take
all necessary actions to ensure that their manufacturing process produces
devices that are manufactured in accordance with the documentation submitted to
the competent authorities.
The statement provided by the manufacturer of the
custom-made device as mentioned above shall be kept for a period of atleast 10
years at the disposal of competent authorities after the custom-made device has
been placed on the market.
If the custom-made device is an implantable device,
the statement provided by the manufacturer shall be kept for a period of
atleast 15 years at the disposal of competent authorities after the custom-made
device has been placed on the market.
The experience gained during the post-production phase
of the custom-made device shall be reviewed and documented by the manufacturer,
including from Post Market Clinical Follow-up as referred in Part B of Annex
XIV. The manufacturer of the custom-made device shall also implement
appropriate means to apply any corrective action.
The manufacturer of the custom-made device shall
report to the competent authorities about any serious incident or field safety
corrective actions or both as soon as the manufacturer learns about them. The
reporting to the competent authority shall be in accordance with Article 87(1),
Reporting of serious incidents and field safety corrective actions.
Now I hope you have acquired some basic knowledge about the requirements of custom-made devices as per EU MDR 2017/745. We will meet again with another valuable topic related to Biomedical Engineering, Medical Device, Healthcare.
NOTE: Dear friends!!!... Please do comment a topic related to Biomedical, so that we can discuss it in future blogs.
Check out for this blog about Computed Tomography, X ray, MRI scan, ECG.
COMPUTED TOMOGRAPHY|TECHNOLOGY|ARTIFACTS
x ray machine working principle
Check out for the below blogs about IEC 62304 & IEC 60601-1.
IEC 62304 Software Configuration Management & Problem Resolution Process
IEC 62304 Software Maintenance Process
IEC 62304 Software System Testing
IEC 62304 Software Unit Implementation & Integration
IEC 62304 Software Architectural & Detailed Design
IEC 62304 Software Requirements Analysis
IEC 62304 Software Development Planning
IEC 62304 Overview & Definitions
IEC 60601-1 Classification of Medical Electrical Equipment
IEC 60601-1 General Requirements for Testing Medical Electrical Equipment
IEC 60601-1 Medical Electrical Systems
IEC 60601-1 Protection against unwanted and excessive radiation hazards
IEC 60601-1 General Requirements
IEC 60601-1 Programmable Electrical Medical Systems
IEC 60601-1 Hazardous situations and fault condition
No comments:
Post a Comment